American Journal of Kidney Diseases
Volume 52, Issue 6 , Pages 1096-1103 , December 2008

Phenotypic and Functional Analysis of Human SLC26A6 Variants in Patients With Familial Hyperoxaluria and Calcium Oxalate Nephrolithiasis

  • Carla G. Monico, MD

      Affiliations

    • Mayo Clinic Hyperoxaluria Center, Division of Nephrology and Hypertension, Departments of Internal Medicine and Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
    • Corresponding Author InformationAddress correspondence to Carla G. Monico, MD, Mayo Clinic Hyperoxaluria Center, Departments of Internal Medicine and Pediatric and Adolescent Medicine, Divisions of Nephrology and Pediatric Nephrology, Mayo Clinic College of Medicine, Rochester, MN 55905
    • ,
  • Adam Weinstein, MD

      Affiliations

    • Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
    • ,
  • Zhirong Jiang, MD, PhD

      Affiliations

    • Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
    • ,
  • Audrey L. Rohlinger, BS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, MN
    • ,
  • Andrea G. Cogal, BS

      Affiliations

    • Mayo Clinic Hyperoxaluria Center, Division of Nephrology and Hypertension, Departments of Internal Medicine and Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
    • ,
  • Beth B. Bjornson

      Affiliations

    • Mayo Clinic Hyperoxaluria Center, Division of Nephrology and Hypertension, Departments of Internal Medicine and Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
    • ,
  • Julie B. Olson, RN

      Affiliations

    • Mayo Clinic Hyperoxaluria Center, Division of Nephrology and Hypertension, Departments of Internal Medicine and Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
    • ,
  • Eric J. Bergstralh, MS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, MN
    • ,
  • Dawn S. Milliner, MD

      Affiliations

    • Mayo Clinic Hyperoxaluria Center, Division of Nephrology and Hypertension, Departments of Internal Medicine and Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN
    • ,
  • Peter S. Aronson, MD

      Affiliations

    • Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT

Received 18 April 2008 ,Accepted 7 July 2008.

References 

  1. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: A 25-year study in Rochester, Minnesota. Kidney Int. 1979;16:624–631
  2. Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;22:893–899
  3. Hiatt RA, Friedman GD. The frequency of kidney and urinary tract diseases in a defined population. Kidney Int. 1982;22:63–68
  4. Herring LC. Observations on the analysis of ten thousand urinary calculi. J Urol. 1962;88:545–562
  5. Goldfarb DS, Fischer ME, Keich Y, Goldberg J. A twin study of genetic and dietary influences on nephrolithiasis: A report from the Vietnam Era Twin (VET) Registry. Kidney Int. 2005;67:1053–1061
  6. Monga M, Macias B, Groppo E, Hargens A. Genetic heritability of urinary stone risk in identical twins. J Urol. 2006;176:127–131
  7. Haleblian GE, Cantor DA, Sur RL, Assimos DG, Preminger GM. Nephrolithiasis in identical twins: The impact of nature vs nurture. BJU Int. 2007;100:621–623
  8. Hesse A, Strenge A, Vahlensieck W. Oxalic acid excretion of calcium oxalate stone formers and of healthy persons. In:  Ryall R,  Brockis JG,  Marshall V, et al. editor. Urinary Stone. New York, NY: Churchill Livingstone; 1984;p. 57–62
  9. Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB. Risk factors in calcium stone disease of the urinary tract. BJU. 1978;50:449–454
  10. Monico CG, Persson M, Ford CG, Rumsby G, Milliner DS. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int. 2002;62:392–400
  11. Van Acker KJ, Eyskens FJ, Espeel MF, et al. Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: A novel type of primary hyperoxaluria. Kidney Int. 1996;50:1747–1752
  12. Jiang Z, Asplin JR, Evan AP, et al. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet. 2006;38:474–478
  13. Freel RW, Hatch M, Green M, Soleimani M. Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null nice. Am J Physiol Gastrointest Liver Physiol. 2006;290:G719–G728
  14. Lohi H, Kujala M, Kerkelä E, Saarialho-Kere U, Kestilä M, Kere J. Mapping of five new putative anion transporter genes in human characterization of SLC26A6, a candidate gene for pancreatic anion exchanger. Genomics. 2000;70:102–112
  15. Waldegger S, Moschen I, Ramirez A, et al. Cloning and characterization of SLC26A6, a novel member of the solute carrier 26 gene family. Genomics. 2001;72:43–50
  16. Lohi H, Lamprecht G, Markovich D, et al. Isoforms of SLC26A6 mediate anion transport and have functional PDZ interaction domains. Am J Physiol Cell Physiol. 2003;284:C769–C779
  17. Jiang Z, Grichtchanko II, Boron WF, Aronson PS. Specificity of anion exchange medicated by mouse Slc26a6. J Biol Chem. 2002;277:33963–33967
  18. Chernova MN, Jiang L, Friedman DJ, et al. Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: Differences in anion selectivity, regulation, and electrogenicity. J Biol Chem. 2005;280:8564–8580
  19. Knauf F, Yang CL, Thomson RB, Mentone SA, Giebisch G, Aronson PS. Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells. PNAS. 1998;16:9425–9430
  20. Xie Q, Welch R, Mercado A, Romero MF, Mount DB. Molecular characterization of the murine Slc26a6 anion exchanger: Functional comparison with Slc26a1. Am J Physiol Renal Physiol. 2002;283:F826–F838
  21. Wang Z, Petrovic S, Mann E, Solelmani M. Identification of an apical Cl(-)/HCO2(-) exchanger in the small intestine. Am J Physiol Gastrointest Liver Physiol. 2002;282:G573–G579
  22. Wilson DM, Liedtke RR. Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: Reference values and sample handling procedures. Clin Chem. 1991;37:1229–1235
  23. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science. 1995;269:92–95
  24. Hassan HA, Mentone S, Karniski LP, Rajendran VM, Aronson PS. Regulation of anion exchanger Slc26a6 by protein kinase C. Am J Physiol Cell Physiol. 2007;292:C1485–C1492
  25. Kocinsky HS, Dynia DW, Wang T, Aronson PS. NHE3 phosphorylation at serines 552 and 605 does not directly affect NHE3 activity. Am J Physiol Renal Physiol. 2007;293:F212–F218
  26. Curhan GC, Taylor EN. 24-H uric acid excretion and the risk of kidney stones. Kidney Int. 2008;73:489–496
  27. Robertson WG, Peacock M. The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria?. Nephron. 1980;26:105–110
  28. Robertson WG, Hughes H. Importance of mild hyperoxaluria in the pathogenesis of urolithiasis—New evidence from studies in the Arabian peninsula. Scanning Microsc. 1993;7:391–401
  29. Clark JS, Vandorpe DH, Chernova MN, et al. Species differences in Cl-affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl-exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis. J Physiol. 2008;586:1291–1306
  30. Karniski LP, Lotscher M, Fucentese M, Milfiker H, Biber J, Murer H. Immunolocalization of sat-1 sulfate/oxalate/bicarbonate anion exchanger in the rat kidney. Am J Physiol. 1998;275:F79–F87

 Originally published online as doi:10.1053/j.ajkd.2008.07.041 on October 28, 2008.

PII: S0272-6386(08)01305-X

doi: 10.1053/j.ajkd.2008.07.041

American Journal of Kidney Diseases
Volume 52, Issue 6 , Pages 1096-1103 , December 2008

Article Tools

* Image Usage & Resolution